RegeneRx Biopharmaceuticals, Inc./ US75886X3061 /
13/06/2024 21:08:44 | Var. -0.0508 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
0.0014USD | -97.32% | 474 Fatturato: .6608 |
-Quantità in denaro: - | -Quantità in lettera: - | 0.0014 | 0.0014 |
GlobeNewswire
01:58
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire
01:19
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Inquire About Securit...
GlobeNewswire
01:16
Inari Medical Faces Lengthy DOJ Probe and Investor Suit Over Potential Kickbacks to Doctors– Hagens ...
GlobeNewswire
00:59
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Couns...
GlobeNewswire
00:58
Contact Hagens Berman by August 6, 2024 Deadline to Join Class Action Against FAT Brands (FAT, FATBB...
GlobeNewswire
00:57
Malibu Boats (MBUU) Under Fire After Securities Class Action Filed – Hagens Berman
GlobeNewswire
00:45
Equinix (EQIX) Financials Under Scrutiny as Short Seller Dispute Intensifies - Hagens Berman June 1...
GlobeNewswire
00:43
Autodesk (ADSK) Accounting Probe Finds Manipulation of Financial Metrics– Hagens Berman
GlobeNewswire
00:22
Reno and TMWA Awarded $30 Million Federal “WaterSMART” Grant for Advanced Purified Water Facility